.png){kind=icon}
返回
Bayesian Uncertainty Directed Trial Designs
.png){kind=icon}
OA
AI
DOI：10.1080/01621459.2018.1497497.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Most Bayesian response-adaptive designs unbalance randomization rates toward the most promising arms with the goal of increasing the number of positive treatment outcomes during the study, even though the primary aim of the trial is different. We discuss Bayesian uncertainty directed designs (BUD), a class of Bayesian designs in which the investigator specifies an information measure tailored to the experiment. All decisions during the trial are selected to optimize the available information at the end of the study. The approach can be applied to several designs, ranging from early stage multi-arm trials to biomarker-driven and multi-endpoint studies. We discuss the asymptotic limit of the patient allocation proportion to treatments, and illustrate the finite-sample operating characteristics of BUD designs through examples, including multi-arm trials, biomarker-stratified trials, and trials with multiple co-primary endpoints. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement.
Keyword:
Decision theory
Information theory
Multi-arm clinical trials
Response-adaptive designs
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
J
IF:
3
论文数:
5.2K
被引数:
4.8W
机构
引用论文
Enhanced Calcitonin Release in Chronic Renal Failure Depending on the Absence of Severe Secondary Hyperparathyroidism.png)
Nephron
NephronIF0
PREAI
分享收藏分享收藏Cognitive Processing in Migraine: A Failure To Find Facilitation in Patients with AuraCephalalgia
CephalalgiaIF0
PREAI
分享收藏
查看更多内容